Please login to the form below
Teva offloads women's health unit in quickfire deals
The Israeli pharma group is also set to sell its oncology and pain business
Merck & Co buys another immuno-oncology target
Will acquire German biotech Rigontec for €115m
PharmaLex strikes up AI collaboration with Volv
The duo will develop pharmacovigilance products and services
Vas Narasimhan takes top Novartis job on Jimenez departure
The soon-to-be CEO will take over at a time when the company has a strong pipeline
Merck mulls sale of consumer health division
The German pharma group will focus on its science and technology businesses
Indivior slumps as patent dispute rises US generic spectre
The RB spin out will appeal against the ruling
Amgen signs real world study and mobile data partnership
Will work with health and wellbeing group Humana on risk prevention
J&J expands its TB research programme
Partners with Indian groups CSIR and IMTECH to develop new treatments
Lilly planning early re-file for JAK inhibitor baricitinib
The arthritis treatment could reach US market a year earlier than expected
Standing out in a crowd
Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Focus on value: A prescription for pharmaThe pricing debate demands a common language to be developed
-
Gilead makes $11.9bn play for CAR-T specialist Kite The agreement is due to close in this year’s fourth quarter
-
Intra-Cellular plans schizophrenia filing in 2018Says lumateperone could provide additional benefits over existing treatments
-
European Research Council readies €2bn in science fundingAims to reward potential breakthrough discoveries
-
Stada's €4.1bn takeover goes throughGerman pharma company finally comes under new ownership
-
Samsung deal with Takeda looks beyond biosimilarsThe duo plan to develop “multiple novel biologic therapies”
-
Trump disbands CEO councils after more defectionsJ&J’s Gorsky resigns following Trump's remark about Charlottesville
-
Quantum Pharma confirms Clinigen takeover bidClinigen has until September 13 to make a formal offer
-
Teva's Mark Salyer joins AmarinTakes up newly-created chief commercial officer role
-
Ljubisav Matejevic joins health IT firm Ascom
He is appointed to central and eastern Europe role
-
Neovii Pharmaceuticals promotes Juergen Pohle to CEOHe will take over from Alexandre Sudarskis in January
-
Bayer appoints Wolfgang Nickl as chief financial officerHe will succeed Johannes Dietsch on June 1, 2018
-
Paul Stockdale joins Oxford BioDynamics as CFO
He takes over from Katie Long at the UK biotech
Latest sales appointments
Featured jobs
-
Medical Writer
-
Competitive Salary
- Director of Rare Diseases, Healthcare Agency, London
-
Excellent Package
- Editorial Director, Medical Communications, London
-
Excellent package
-
Account Director
-
Salary TBC
-
Programme Director
-
Salary TBC
- Senior Medical Writer, Medical Communications, London
-
Excellent package
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35, 000 according to skills and experience
- Principal Medical Writer, Medical Communications, London
-
Excellent package
Subscribe to our email news alerts
- Novartis looks outside pharma for digital transformation
- Merck to co-lead new oncology big data alliance
- Sandoz says Humira biosimilar clears clinical hurdle
- GSK closes in on EU approval for triple COPD therapy
- Amgen's Mvasi is first FDA-approved cancer biosimilar
- Roche faces prospect of second Rituxan biosimilar in US
PMHub
Dovetail
Transforming healthcare through effective collaboration. Making work to feel proud of.
www.dovetailstrategies.com...
Latest intelligence
- Why AI might be the rep’s best friend
- When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
- How Transparent Is Transparency?
- The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
- LEO: Patients benefit from transparency
- Paving the way for openness in pharma...
Quick links
Infographics
